Meds

Meds

Private
SwedenHealthcare & Life Scienceshttps://www.meds.se

Last Round

IPO Announced

Sep 23, 2025

Est. Valuation

$117.97M

Total Funding Raised

$31.13M

Momentum Score

25 /100

Company Overview

Meds Apotek AB operates as a full-scale online pharmacy in Sweden, selling prescription and non-prescription medicines, as well as a wide range of health and beauty products. The company operates with a license from the Swedish Medical Products Agency and focuses on providing fast, direct-to-consumer deliveries without physical stores. Founded in 2017 and launched in 2018, Meds aims to be Sweden's favorite online pharmacy. The company is venture capital-backed and is headquartered in Stockholm, Sweden.

Sector

Healthcare & Life Sciences

Verticals

E-commerce, Pharma Supply Chain, Last-Mile Delivery, Fashion & Beauty, Retail Technology

Business Model

B2C

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

online pharmacyprescription medicationdigital pharmacye-commerce pharmacyover-the-counter medicinesOTC medicinesonline apotekfast home deliverydirect-to-consumerD2Cmail-order pharmacyhealth and wellness e-commercelast-mile deliverypet pharmacybeauty e-commercepharmaceutical advising

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Meds Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Meds Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
IPO AnnouncedSep 23, 2025
VC RoundApr 27, 2023
VC RoundJun 23, 2022
Series BJan 21, 2021
Private PlacementNov 20, 2019
Series A
Jan 10, 2019

Key People

Founding team and executive leadership

Adham Shawwaf

Co-founder And CTO At MEDS, COO

Founding Team

Björn Thorngren

Founder And CEO

Founding Team

Meds Investors

Notable investors and investment history

InvestorRounds
Ahlström InvestIPO
Carl WestinSeries B
Inbox CapitalPrivate Placement, Series B, Series A
CNI NordicSeries B, Series A
Cicero FonderIPO
Swedbank RoburIPO
TIND Asset ManagementIPO

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 23, 2025

    $29.35M raised in IPO round.

Meds Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Meds Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Meds's valuation, stock price, and market status.

Firmographic Details

HeadquartersSweden
Employee Range84
Year Founded2017
Last FundingSep 23, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.